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Abstract
Rod-shaped gold nanoparticles exhibit intense and narrow absorption peaks for light in the far-
red and near-infrared wavelength regions, due to the excitation of longitudinal plasmons. Light
absorption is followed predominantly by non-radiative de-excitation, and the released heat and
subsequent temperature rise cause strong photoacoustic (optoacoustic) signals to be produced.
This feature combined with the relative inertness of gold, and its favorable surface chemistry which
permits anity biomolecule coupling, has seen gold nanorods (AuNR) attracting much attention
as contrast agents and molecular probes for photoacoustic imaging. In this article we provide an
short overview of the current status of the use of AuNR in molecular imaging using photoacoustics.
We further examine the state-of-the-art in various chemical, physical and biochemical phenomena
that have implications for the future photoacoustic applications of these particles. We cover the
route from ne-tuning of AuNR synthetic procedures, toxicity reduction by appropriate coatings,
in vitro cellular interactions of AuNRs, attachment of targeting antibodies, in vivo fate of the
particles and the eects of certain light interactions with the AuNR.
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I. BACKGROUND
Fine particles of noble metals in the nanometric size range possess intense and spectrally
narrow absorption and scattering peaks in their interactions with light [1]. This feature
endows dispersions of these nanoparticles with vivid colors, a property that was recognized
early on by craftsmen in the Middles ages (and perhaps earlier - see Ref. [2]), who used gold,
silver and alloyed powders in glass to make stained glass window panels with distinctive reds,
purples and yellows. In 1857 Michael Faraday developed the rst scientic underpinnings to
these observations with his experiments on light interactions with metal particles \minute in
their dimensions" [3]. He had been especially fascinated by the ruby-red appearance of gold
dispersions in water. In 1908, Gustav Mie [4] laid the mathematical foundation which could
be used to explain the dependence of the optical properties on the sizes of nely divided gold.
Mie solved Maxwell's equations for light interaction with small spheres [5]. The material of
the sphere possesses a complex frequency-dependent dielectric function (!)=1(!) +i2(!),
and the embedding material is water with a frequency-independent dielectric function m.
From Mie's theory, under the dipole approximation, the extinction cross-section e(!) is
given by:
e(!) _
!
3=2
m 2(!)
[1(!) + 2m]2 + 2(!)2
(1)
For a certain frequency of light, 1 achieves a value equal to  2m which causes e to `blow
up' [5]. Gold spheres smaller than 20 nm achieve this resonance condition at 516 nm in the
green region of the spectrum, which explains the ruby-red color of gold nanospheres [6].
A physical meaning can be obtained by considering that the free electrons of the noble
metal interact electrostatically forming an electron plasma which can be excited by light of
the appropriate energy to perform uid-like oscillations [7]. This plasma possesses, just like
an oscillator, a resonance frequency. In quantum mechanical parlance one says that a local-
ized surface plasmon (LSPR) is excited at resonance. In the case of gold at the nanoscale,
the boundaries conne the oscillation and resonance occurs at the visible frequencies. At
this wavelength, light is most eectively coupled to the metal particle and the interaction
(absorption and/or scattering) will peak.
If the geometrical symmetry of the gold particle is disturbed from the spherical, with
elongation of the particle in one direction, plasmons can be excited along the two available
axes for a scrambled polarization of light. Oscillations directed along the short axis give rise
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to an interaction peak called the transverse plasmon (TP) peak, oscillations along the major
axis give rise to a lower energy longitudinal plasmon (LP) peak. The spectral location of
the TP peak remains relatively xed around 516 nm, while the LP peak position is sensitive
to the aspect ratio (AR) of the particle; the higher the AR the higher is the red-shift [5].
Such nanoparticles in the form of hemispherically-capped cylinders called nanorods (NRs)
can be synthesized with an excellent control of aspect ratios providing LP peaks in the red
and near-infrared (NIR) wavelengths [8, 9].
The ability to tune the nanorods' strong and narrow LP absorption peak in the range
of 650-1100 nm makes the particles attractive for optical imaging in tissue [10]. In this
wavelength regime, tissue exhibits as it were, a spectral `window', where light is able to
penetrate fairly deep due to low absorption and low scattering by tissue [11, 12]. Further,
the particles' absorbed photon energy is rapidly thermalized by electron-electron collisions
and transferred to the lattice by electron-phonon collisions to achieve ecient photothermal
conversion [5]. These characteristics make gold nanorods (AuNR) a boon for photoacoustic
(also called optoacoustic) imaging, which relies on absorption of pulsed light to generate
ultrasound due to rapid heating and thermoelastic expansion. If these AuNRs could be made
to accumulate at the disease site of interest, then a sensitive and specic detection/diagnosis
of the pathology could be achieved using photoacoustic imaging.
Oraevsky was the rst to recognize this potential synergy between AuNRs and photoa-
coustic imaging, and he advocated as far back as 2001 [13] the use of these particles, among
others, as contrast agents in the spirit of molecular imaging. Since then much knowledge has
been gained in the photoacoustic imaging community in the use of these [14{26] and other
plasmonic nanoparticles such as gold nanoshells [27], nanocages [28, 29] and gold nanobea-
cons [30]. Photoacoustic (PA) imaging experiments have been conducted using AuNR in
phantoms, in cells in vitro and in murine/rodent models of disease. Highlights of the small
animal in vivo work are summarized in the next paragraphs
In 2007, Eghtedari et al [19] demonstrated that AuNR could be detected in vivo in a mouse
using the laser optoacoustic imaging system (LOIS) which employed a 32-element ultrasound
detector and pulsed light at 757 nm from an Alexandrite laser. The authors visualized
higher signals arising from the presence of PEGylated AuNRs injected subcutaneously into
the abdominal region of a nude mouse at the LP peak of the particles. Agarwal et al [21]
imaged gel beads dispersed with AuNR implanted in the hind leg of a mouse using a hybrid
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ultrasound (US)-photoacoustic (PA) system where a clinical ultrasonography system was
synchronized to a laser. They obtained co-registered US and PA images, the latter showing
the presence of AuNR with anatomical contexts obtained from US. In 2008, the groups of
P.-C. Li and C.-R. C. Wang who were active in many aspects of synthesis and applications of
AuNR, published the rst clear demonstration of molecular imaging using antibody coupled
AuNR[23]. They conjugated two samples of AuNRs to anti-EGFR and anti-HER2 antibodies
respectively. Two types of tumors were induced in the backs of mice by implantation of oral
cancer (OECM1) cells which overexpress HER2 receptors, and squamous cell carcinoma
(Cal27) cells which overexpress EGFR receptors. A home-made PA imager using a LiNbO3
transducer coupled to appropriate lasers was used to show the selectivity that could be
obtained using the appropriate targeted AuNR. Figure 1 panel (a) shows an example of an
overlay of the pseudocolor PA image on the gray scale US image in the left column, and the
PA image in gray scale in the right column of a Cal27 tumor when AuNR1064-EGFR are
injected into a mouse[23].
In 2009, the group of L.-H. Wang[24] used AuNR as a tracer in PA mapping of lymph
drainage to identify sentinel lymph nodes in rat models. The system used was a deeply
penetrating PAmicroscopy system. Cui et al [31] also used PAmicroscopy in 2010 to visualize
AuNR accumulated at a tumor site in a mouse model, to guide the application of high-
intensity focussed ultrasound (HIFU) for therapy. In the same year, Taruttis et al [26] showed
real-time imaging of circulating AuNR in blood vessels in the neck region of a mouse injected
with the particles. They used a 10 frame per second acquisition system for signals from a
64-element ultrasound detector array with the mouse illuminated from multiple directions to
obtain multiple wavelength images using their multispectral technique (MSOT)[32]. Figure 1
panel (b) shows the comparison of the cryosection of the neck region of the mouse with the
PA images processed using MSOT of the same region pre- and post-injection of the AuNRs.
Other such feasibility studies have been discussed in a few excellent review articles[33]. In
this overview article, we will not tread this path, as this is tantamount to a mere update of the
published reviews. Rather we will critically examine the state-of-the-art in various chemical,
physical and biochemical phenomena that have crucial implications in the future applications
of these particles in PA imaging. The reader will be taken along the trajectory from ne-
tuning of AuNR synthetic procedures, toxicity reduction by appropriate NR coatings, in
vitro cellular interactions of NRs, attachment of targeting antibodies, in vivo fate of the
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FIG. 1. Panel (a) shows images of Cal27 tumor before and after the injection of AuNR1064-EGFR.
Ellipses indicate the tumor regions. Left column show fusion images before/after the injection at
dierent time points. The ultrasound images are displayed on a grayscale, and the superimposed
PA images obtained at an optical wavelength of 1064 nm are displayed in red pseudocolor. Right
column show PA images before/after injection shown in the same scale. (Panel (a) adapted from
Ref. [23] with permission from authors and the Optical Society of America (OSA), copyright 2008.)
Panel (b): From top to bottom (i) Photograph of cryosection showing anatomical correspondences
with jugular veins labeled JV, (ii) Multi Spectral Optoacoustic Tomographic (MSOT) image before
injection, (iii) MSOT image post-injection showing multispectrally resolved distribution of AuNR
overlaid on a single wavelength image. Scale bar 3 mm. (Panel (b) adapted from Ref. [26] with
permission from authors and the Optical Society of America (OSA), copyright 2010.)
particles and the eects of certain light interactions with the AuNR.
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II. SYNTHESIS OF GOLD NANORODS
Rod shaped gold nanoparticles were initially prepared by depositing gold in porous tem-
plates using electrochemical and photochemical methods[34]. Attention shifted to wet-
chemistry methods with the development of the seeded-growth method by Murphy and
co-workers et al [35, 36]. Gold spheres were used to seed a growth solution comprising
gold salt and ascorbic acid (AA) as a mild reducing agent in the presence of a surfactant
cetyltrimethylammonium bromide (CTAB). The latter is thought to form `soft' micellar
templates for AuNR formation with medium to high aspect ratios (5-20).
Jana et al [37] used silver ions during the seeded-growth procedure, a feature that was
further investigated and improved by Nikoobakht and El-Sayed [38] to achieve spectacular
yields of AuNR (upto 100% yield up from the 20-40% yield without silver ions) with excellent
monodispersity. Importantly, they showed the ne control that was possible in tailoring
the aspect ratios (AR) of the AuNR by changing the quantity of Ag+ ions in the growth
solution. The mechanism at work in this protocol has been debated in the recent past.
In solution-phase synthesis the nal shape of the nanoparticles is driven by the inuence
of capping agents [39]. In the case of gold nanorod synthesis, it has been discussed that
CTAB (and Ag+) stabilize the 110 faces to a greater extent than the f100g surfaces of the
growing Au seed leading to a faster rate of Au atom growth on the latter, and consequently
one-dimensional growth along the [100] direction [40{42].
A. The seed-mediated silver assisted protocol
The Nikoobakht and El-Sayed [38] method with small variations [43{46], remains the
most popular method for synthesizing AuNRs. We describe briey our version of the protocol
that works well. Figure 1 depicts a schematic of the procedure.
1. Preparation of growth solution: To freshly prepared 0.5 ml of 0.01 M gold salt
(HAuCl4) solution, is added 9.5 ml of 0.1 M CTAB solution with thorough mixing
to yield a dark yellow solution. (Flask A in Fig. 1.) Using dierent AgNO3 concentra-
tions in the growth solution allows a tuning of the LP peaks between 650{950 nm. To
illustrate the AuNR size and LP wavelength tuning eect of AgNO3 we use 8 volumes
of 0.01 M of AgNO3 (20, 50, 70, 100, 200, 250, 300 and 350 l), to provide 8 growth
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solutions. To these, 55 l of 0.1 M ascorbic acid is added with stirring. The resultants
turn colorless.
2. Preparation of gold seed: To 0.25 ml of 0.01 M HAuCl4 solution, 9.75 ml of 0.1
M CTAB is added with stirring. (Flask B in Fig. 1.) 0.01 M sodium borohydride
(NaBH4) solution in a volume of 0.6 ml is added to the mixture all at once with
vigorous stirring for 2 minutes. The resultant is used within about 5 minutes to seed
each growth solution.
3. Growth phase: The seed solution is added in a volume of 12 l to the growth solutions
with gentle stirring. The resultants are maintained undisturbed at 25oC for 24 hours.
At the bottom of the vessel, a dark-blue suspension is seen with a brownish opalescence.
The contents of the vessel are centrifuged and the precipitates re-dispersed in 10 ml
of water.
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HAuCl
AgNO
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4
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with 30 sec  
gentle stirring
solution turns 
  colourless
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heat in oil 
bath 2 min
with stirring
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FIG. 2. Schematic of the seed-mediated silver assisted protocol for synthesizing gold nanorods.
See text for details.
We used gold salt (Tetrachloroauric acid HAuCl4.3H2O, 99.99%) from Acros Organics (Bel-
gium), sodium borohydride (NaBH4, 99%), and ascorbic acid (99%) from Aldrich (The
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FIG. 3. (a) Optical extinction spectra of AuNR synthesized using various Ag+ concentrations in
the growth solutions. Signature transverse plasmon (TP) peaks are seen around 516 nm. Red-
shifted longitudinal plasmon (LP) peaks in each spectrum indicate the presence of AuNR. (b) A
scanning electron micrograph (SEM) of AuNR for the case when 50 l of 0.01 M AgNO3 was used.
(Reprinted from Ref [47] with permissions from the authors and the American Chemical Society,
copyright 2010 .)
Netherlands), silver nitrate (AgNO3, 99.8%) from Merck (Germany). The CTAB used was
product Acros 22716V. Excellent AuNR samples are obtained as witnessed in signature LP
peaks in optical extinction spectra, these peaks spanning the spectral range of interest in
biomedical imaging (Fig. 3(a)). The SEM image of particles synthesized when 50 l of
AgNO3 are used is shown in Fig. 3(b).
The success of the above procedure depends upon several factors including the use of clean
glassware and stirrers. We studied the eect of various methods of cleaning glassware. The
simplest method was the use of a laboratory steam dishwasher followed by 3 rinsing steps
using deionized water. Reasonably high yields of AuNR were synthesized with reproducible
LP peaks at the designed wavelengths when the glassware was relatively new. However
for best results with highest yields and excellent reproducibility we recommend that all
glassware be rinsed with hydrouoric acid (HF), further with aqua regia (HCl/HNO3) and
rinsed thoroughly with deionized water prior to use.
Only Milli-Q Gradient System water (Millipore, Bedford, MA, USA) is used for preparing
solutions. We prepare the CTAB solution by progressive addition of the akes to Milli-Q
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water maintained at around 45oC in an ultrasonic bath. Gold salt and borohydride solutions
need to be freshly prepared, and the latter should be kept ice cold till required.
The chemicals used are crucial for the success of the protocol. Smith and Korgel [46, 48]
showed that it was not possible to synthesize AuNR using CTAB products from certain
suppliers, which they found to contain iodide impurities. We showed[47] that even within
a certain CTAB product, iodide impurities can vary signicantly from lot to lot. It should
not be a forgone conclusion that AuNR can or cannot be synthesized using certain CTAB
products just based upon supplier name and product number; a lot number is required to
make such judgements.
One should be aware that it is not possible to exclude variations in environmental con-
ditions such as in ambient temperature etc., uncertainties in experimental conditions such
as in seed aging times, component concentrations etc., which could aect in complex ways
various steps in the trajectory followed for making AuNR. Thus, if the above protocol fails
to produce AuNR, before one changes the CTAB product for another, we recommend that
one resort to tweaking concentrations of various products added (starting with AgNO3) or
ne-tune certain experimental conditions.
III. OPTICAL CHARACTERIZATION OF GOLD NANORODS
An accurate estimation of the optical absorption coecient spectrum (a()) is impor-
tant to feedback the synthesis procedure regarding suitability of LP wavelength and the
concentrations of NRs (Nd) produced. Further, the photoacoustic response following optical
absorption is dependent on the N and their a. Knowledge of these two parameters will
help in moving towards predicting response, though this response will be heavily modulated
by the optical properties of surrounding tissue which will determine the number of photons
that will be available for absorption.
Conventional spectroscopy in a vis-NIR photospectrometer is the choice for determining
optical properties by measuring collimated transmission spectrum and applying the Beer-
Lambert law to calculate the extinction coecient (e):
e =  1
d
ln

I
I0

(2)
where d is the cuvette length, I=I0 is the transmitted light intensity.
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This approach is suitable to ascertain the position of the LP peak. However, determining
a from the measurement is not straightforward since most particles considered for photoa-
coustics have their largest dimension greater than 50 nm, when their scattering coecient
s becomes non-negligible.
The following approach is usually adopted: the average size of the particles is ascertained
using electron microscopy (EM). With the value of dielectric function of gold and that of the
embedding material (water), the optical interaction eciencies (Qe; Qa; Qs) are calculated
using numerical methods such as the Discrete Dipole Approximation (DDA) [49]. Knowing
the geometrical cross-sections, the interaction cross-sections (e; a; s) can be calculated.
Under the assumption that the particles are clones of the simulated particle, the number
density (Nd) of the particles is calculated from the extinction coecient (e) as:
Nd =
e
e
(3)
Absorption/scattering coecients are now calculated as:
a=s = Nd  a=s (4)
This method has the drawback that in the literature for the popular implementation of
the DDA method there are inconsistencies in the choice of various parameters required for
the simulations which lead to considerable inaccuracies in the results. We provide a critical
discussion of the most important input required for accurate modelling.
A. DDA simulations of optical properties
DDSCAT 6.1 [50] is a FORTRAN package that implements the DDA method to simulate
interaction of electromagnetic radiation with particles of arbitrary shape and composition.
The particle is subdivided into N polarizable points, located on a cubic lattice with an
interdipole distance d given by V = Nd3 where V is the volume of the particle. The radiation
scattered and absorbed by the target is computed taking into consideration dipole-dipole
interactions.
The output parameters from the simulation are extinction, absorption and scattering
eciencies (Qe, Qa, Qs) which yield the corresponding cross-sections of the particle when
multiplied by r2eff . The eective radius reff is the radius of a sphere having a volume equal
to that of the particle and is given by (3V=4)1=3.
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As mentioned earlier, no universal agreement exists on a number of parameters in the
use of DDSCAT such as the number of dipoles chosen for discretization, on the shape used
to represent the nanorods and on the dielectric function of gold required for the simulations.
In Ref. [51] we systematically studied the inuence of these parameters on simulated results,
but here we will discuss only the choice of dielectric function which is of great importance
in the simulations. Prior reports used without justication experimental data tabulated by
either Johnson and Christy [52], Palik [53] or Weaver [54]. Further, sometimes bulk values
and at other times size corrections modications to account for surface damping have been
used. With all other parameters remaining the same, a wide spread in the position of the
LP maximum is obtained for the dierent sources for the dielectric function. We found that
there is reasonable consistency between our experiments and simulation with the use of size-
corrected data from Palik [53], which could be the best choice for the dielectric function. The
dielectric function of gold from Palik [53] was determined under ultrahigh vacuum conditions
which suggests reliability. However, much still needs to be learnt regarding the dielectric
function of gold at the nanoscale.
B. Experimental quantitation of optical properties
We have shown that it is not possible to objectively compare experimental data with
the simulations owing to the various input parameters, such as the shape (not discussed
here) used to represent the NRs and the dielectric function of gold. Consequently, the value
estimated for e can be inaccurate; the errors propagating in subsequent calculation steps
to the values of absorption a and scattering s coecients.
Currently, only a few experimental techniques have been reported against the backdrop
of the limitations of the conventional approach. The photoacoustic method [55] is the most
robust since it measures a directly as a driver of the ultrasound detected. The method
requires a previous calibration of the system against an absorber whose a is known.
Recently we presented a novel approach to determine the ensemble optical properties
(both a and s) of AuNR [56]. This method is based on a dual-ber approach called
dierential pathlength spectroscopy (DPS) [57, 58]. One ber delivers and collects (dc)
photons from the sample, the second ber adjacent to the rst, only collects (c) photons. A
schematic of the setup is shown in Fig. 3; details are provided in Ref. [56]. When the photon
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FIG. 4. Dierential pathlength spectroscopy (DPS) experimental setup for determining the optical
properties of small volumes of gold nanorods.(Reprinted from Ref [56] with permissions from the
authors and the American Chemical Society, copyright 2010.)
mean free path is smaller than the ber diameter, the dierential reectance R, obtained by
subtracting the c signal from the dc signal originates from a constant apparent pathlength.
This term, called the dierential pathlength [57, 58], depends only upon the ber diameter,
so that its knowledge allows quantitative determination of the optical properties in highly
scattering media.
When a ber of small numerical aperture (say N. A.= 0.22) is used, the backscattering
signal is given by [56]:
Rsing = Capp bk (5)
where Capp is an instrument constant and bk the backscattering coecient. This bk is
given by:
Rsing = Capp p(180)s (6)
where p(180) is the phase function of scattering sampled at 180o. To determine Capp above,
the DPS system requires calibration against a medium with well-characterized optical prop-
erties such as NIST certied polystyrene beads. Thus, from eq 6, it is clear that the acquired
DPS signal can be related to s.
To convert this to the scattering coecient (s), a theoretical calculation of the phase
function at 180o of the particles is required. We resorted to DDSCAT simulations, but we
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showed that this p(180) is only marginally susceptible to error [56]. This is in sharp contrast
to the inaccuracies in calculated interaction eciencies (Q's) as discussed above. Finally, us-
ing the extinction coecient (e) obtained using a standard UV-vis-NIR photospectrometer
measurement, a is easily obtained.
IV. BIOCOMPATIBILITY OF GOLD NANORODS BY PEG COATING
The surfactant CTAB is crucial for the synthesis of rod-shaped nanoparticles. CTAB
(and silver) stabilize the f110g faces of gold seed to a greater extent than the f100g surfaces
leading to a faster rate of gold atom deposition on the latter, leading to one-dimensional
growth along the [100] direction [40{42]. The CTAB bilayer [59] also helps preserve colloidal
stability by electrostatic repulsion due to its a nett positive charge on the particle surface.
CTAB is thus indispensable for preparing highly monodisperse and stable particles with
controllable aspect ratios [38, 60].
However, CTAB disrupts cell-membrane integrity [61] and is severely toxic. Such CTAB-
AuNR intended for any biomedical applications need to be detoxied by removing excess
unbound CTAB from the dispersing medium by centrifugation. This process however also
strips stabilizing CTAB o the gold, which increases the tendency of the particles to aggre-
gate. It is also possible that CTAB molecules can desorb from the gold surfaces, making the
particles potentially toxic.
An excellent approach to ensure biocompatibility is to PEGylate NRs, which has been
shown to ameliorate cell toxicity in several cell lines [62{65], by largely replacing CTAB.
We expanded the cell-toxicity studies by applying PEGylated nanorods to a number of cell
lines: SKBR3, CHO, C2C12 and HL60 cells [66].
The following is the procedure that we follow [66]: The stock solution is centrifuged at
10000 G for 20 minutes, and the pellet redispersed in water. The centrifugation step is
repeated a second time, with the resulting NR pellet now dispersed in 0.5 ml of 5 mM
mPEG-SH with vigorous vortexing for 20 seconds. To this, 0.5 ml of 1X PBS (Phosphate
Buer Saline) is added followed by continuous rotation for 24 hours at 4oC. The resultant
is subjected to two centrifugation steps to remove excess mPEG-SH from the solution and
the pellet dispersed in 2.5 ml 1X PBS.
The result is strong sulphur binding of the SH terminal of mPEG-SH to the gold surface,
13
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FIG. 5. (a) Model for surface modication of gold nanorods using mPEG-SH, where sulphur-
gold binding ensures replacement of the CTAB bilayer by PEG. (b) Dose-response curves of the
SKBR3 cell-line following exposure to various gold nanorods having longitudinal plasmon peak at
773 nm. Particles studied are AuNR773, ltered AuNR773, PEGylated AuNR773 and PSS-treated
AuNR773. (Adapted from Ref [66] with permissions from the authors and the Institute of Physics
(IOP) Publishing, copyright 2010.)
with replacement of (most of) the CTAB bilayer. A model of the resultant is shown in
Fig. 5(a). Evidence for this can be obtained by measuring zeta-potential values [66] for
the resultant. Neutral to near-neutral values indicate PEG replacement of most of the
positively charged CTAB. In such a case there will be no compromise in colloidal stability,
since the completely formed PEG layer takes over the stabilizing role of CTAB, but with a
steric hindrance mechanism compared with CTAB's elecrostatic or charge stabilization. The
optical spectra of the particles before and after PEGylation should be measured to verify
that the characteristic plasmon peaks are preserved and that the colloid is stable. We have
found that the particles processed in this way with PEG, retain excellent dispersion stability
even after mixing in cell culture media [66].
We found that the PEGylated particles elicited excellent cell viability and were essen-
tially non-toxic for the SKBR3, CHO and C2C12 cell-lines up to concentrations of 165
pm corresponding to approximately 1  1011 NR/ml. Typical dose response curves using
14
products from batch AuNR773 (AuNR with LP peak at 773 nm) on the SKBR3 cell-line
is shown in Fig. 4(b). Further, we found from TEM that PEG-AuNR were absent inside
SKBR3 cells [66] after 3 hours of exposure. In combination with the low toxicity prole this
indicated that PEG-AuNRs have little interaction with cells.
Next we tested the particles in vivo with all the complexity of blood ow, immunolog-
ical and inammatory responses. Specically we compared the blood clearance and tissue
distribution of CTAB-capped and PEG-coated AuNR after intravenous injection in the tail
vein of rats [67]. The gold content in blood and various organs was measured quantitatively
with inductively coupled plasma mass spectrometry (ICP-MS).
The CTAB capped gold nanorods were almost immediately (< 15 minutes) cleared from
the blood circulation whereas the PEG-AuNR resulted in a prolonged blood circulation
with a half lifetime (t1=2) of 19 h [67] (Fig. 5(a)). We surmised that with CTAB-AuNR,
a serum protein `corona' [68{70] comprising opsonin ligands, is immediately formed. This
would initiate mechanisms of recognition and internalization by components of the reticu-
loendothelial system (RES). Rapid clearance of the CTAB-AuNR from blood would follow,
with their deposition into organs of the RES.
On the other hand, the hydrophilic and neutral PEG coating prevents or minimizes
adsorption of serum proteins on the AuNR [71, 72] Further close approach of the underlying
AuNR to cell surfaces is precluded by the PEG layer [71, 72]. The eect is thus minimal
interaction of the AuNR with macrophage cell receptors: PEG-AuNRs thus experience
prolonged blood persistence (see also Fig. 5(b)).
In addition to the dramatic dierences in blood clearance kinetics between the two types
of particles, the nal organ distribution of the particles was also signicantly dierent.
CTAB-AuNR were taken up predominantly by the liver, and to a lesser extent by the spleen
followed by the lungs. On the other hand, the PEG-coating served to shift the distribution
prole more towards the spleen with a 6 day dose per gram organ 6.8 times in excess of that
in the liver, as depicted in Fig. 5(c).
Thus, PEGylation of AuNRs resulted in a prolongation of the blood clearance (up to
48 hours) and the highest organ exposure in the spleen. In view of the time frame of
the observed presence in blood circulation, PEG-AuNR can be considered to be promising
candidates for in vivo use.
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FIG. 6. (a) Blood clearance of PEGylated (PEG-AuNR) and non-PEGylated (CTAB-AuNR) gold
nanorods. (b) Recovery of gold from various harvested organs as percentage of administered dose
for PEG-AuNR and CTAB-AuNR on day 1, and (c) on day 6.
V. BIONJUGATION OF GOLD NANORODS WITH ANTIBODIES
There are broadly two methods of coupling AuNRs with anity biomolecules: using
non-covalent means [10, 73] and covalent means [74, 75].
A. Non-covalent conjugation of the antibody to colloidal gold
This method relies on the existence of negative charge on the particles' surface which
attracts positively charged amino groups of the antibody. When the protein comes close
enough for binding, the hydrophobic pockets of the protein will make contact and bind with
the gold.
In general, for optimum conjugation, it is recommended that the pH of the mAB and gold
sol be maintained at or slightly higher than the isoelectric point (pI) of the antibody [76].
The minimum protecting amount of mAB is incubated with the AuNR for conjugation to
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take place. The minimum protecting amount of protein is that amount that is required to
maintain colloidal stability of the conjugated NPs upon addition of NaCl [76] as judged by
colorimetric analysis. To block the free surfaces on the gold 10 % Bovine Serum Albumin
(BSA) maintained at the same pH as the antibody solution, is added to the resultant.
Using this method, we conjugated gold nanospheres (AuNS) and AuNRs with HER81
antibody, which bind with high eciency to HER81 receptors expressed by SKBR3 breast
carcinoma cells [10]. Citrate capped AuNS are negatively charged due to a layer of negative
citrate ions and are well suited to the method described. With AuNR the situation is more
complex: their sidewalls are stabilized with a CTAB bilayer, which imparts a positive charge
to the surface. We surmised that inspite of the net positive charge, the unpassivated end
faces would be negatively charged due to the presence of AuCl 2 ions [77]. We therefore
followed the same protocol and performed immunostaining studies using the SKBR3 cell-line,
which demonstrated the success of the bioconjugation and the retention of the functionality
of the mAB.
B. Covalent binding of antibodies to gold nanorods
The method of non-covalent binding is expected to be less strong and less stable especially
in the hostile environments found in vivo, and covalent binding is used. As the name
suggests, a linker couples the antibody to the gold surface using covalent coupling. Hu et
al [65] used a heterobifunctional cross-linker LC-SPDP to connect antibodies to the AuNR
surface using the covalent binding of the pyridildithio group to gold. Recently, Eghtedari
et al [78] reported the use of nanothinks acid activated by EDC-NHS to couple antibodies
covalently to AuNR.
We used a heterobifunctional PEG linker (OPSS-PEG-NHS) to achieve covalent coupling
of HER81 antibodies to AuNRs. This strategy was inspired by the work of Loo et al [75]
who used the approach to couple gold nanoshells to HER2 antibody. Figure 6 depicts the
procedure. The following are the steps followed:
1. Coupling of OPSS-PEG-NHS to HER81 mAb The PEG linker is made to couple
to the HER81 via amide bonding via the linker's NHS group. The linker is dispersed
in NaHCO3 (100mM, pH 8.5) and 81 mol/L (0.13 mg/ml) of the resultant is mixed
with 5.4 mol/L (1 mg/ml) HER81 mAb at a volumetric ratio of 1:9. The HER81-
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FIG. 7. Schematic representation of the procedure of covalently coupling the HER81 mAb to the
gold nanorods using a heterobifunctional PEG linker OPSS.
OPSS-PEG-NHS is incubated on ice. The PEGylated mAB is dialyzed (MW=7,000)
to remove excess linker; PBS is used as dialysis buer. The samples are stored at 40
C.
2. Coupling of PEG-linker-HER81 to gold nanorods Two ml of AuNR are cen-
trifuged at 7000 g/20 minutes in a low-binding micro tube. The pellets from several
samples are added to increase the concentration. The AuNR are dispersed in 1 ml
PBS with 100 mM EDTA with gentle mixing.
The PEG-linker-HER81 is added with vortexing to the AuNR and allowed to stand for
two hours. After incubation, 100 l of 2 mM K2CO3 and 12 l of 5 mM mPEG-SH is
added. The resultant is rotated overnight at room temperature (RT); then centrifuged
three times at 7000 g/20 minutes. The pellet is dispersed in 1X PBS and stored at 40
C.
The biconjugation was a success as borne out from confocal microscopy visualizations of
immunostaining studies using the SKBR3 breast adenocarcinoma cell-line. The protocol ap-
peared to be robust and dependable for bioconjugation and the functionality of the product
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FIG. 8. (A) Absorbance spectra showing the longitudinal plasmon (LP) peak of gold nanrods
(AuNR) before (solid line) and after (dashed line) pulsed laser irradiation using 1000 pulses at 120
mJc m 2 at 800 nm. Transmission electron micrographs (TEM) of the AuNR before (B), and after
(C) laser exposure. The AuNR are deformed into spherical particles. (Reproduced from Ref. [81]
with permission from the authors and the Institute of Physics (IOP) Publishing, copyright 2009.)
was stable to well after 6 months.
VI. PULSED LIGHT INTERACTIONS WITH GOLD NANORODS
The thermodynamic tendency to lower surface energy would imply that nanorods are
unstable with respect to nanospheres. Pioneering investigations by Chang et al [79] and
Link et al [80] independently demonstrated that illumination of AuNR with high uences of
pulsed laser light at the LP peaks caused shape transformation towards the thermodynam-
ically favorable spherical shape. Thermal equilibration between electrons and the lattice in
electron-phonon coupling was thought to cause temperatures in excess of melting to cause
the structural rearrangements[5]. At uences lower than a certain not-well dened threshold
sometimes intermediate forms with lower aspect ratios than the original were also observed.
The eect of this shape transformation on the optical properties was spectacular: with suf-
cient numbers of high intensity laser pulses at the LP peak ensemble populations of AuNR
would form spheres, causing the LP to disappear with an accompanying increase in the TP
peak (See Fig. 6). The implication of this LP bleaching from an imaging point of view is a
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loss of contrast at the NIR wavelength of interest. Didychuk et al [81] experimentally studied
the photon-driven AuNR reshaping phenomenon in tissue phantoms dispersed with AuNR,
using ns laser pulses at the LP wavelength, in a combination of energies and pulse counts.
Their most important nding was that at the maximum permissible exposure (MPE) 30
mJ cm 2, for the specications of the laser used, NR conversion to spheres occurred to a
depth of 6 mm after 100 pulses. The implication for PA imaging is that at the MPE, the
use of AuNR for contrast applications is not applicable for depths less than 6-10 mm. For
deeper lying target sites the illuminated particles maintain their morphologies preserving
the necessary sharp absorption peaks at the designed wavelength.
Recent work from the groups of P.-C. Li [82] and Emenialov [83] has shown that the
threshold for photon-induced reshaping can be raised by encapsulating AuNR in an amor-
phous silica matrix. Both groups use a single-step method where an alkoxide-based silica
precursor, tetraethyl orthosilicate (TEOS), is added to the rods at a pH that is adjusted to
around 11. With time, mesoporous silica coatings are uniformly deposited on the AuNRs. It
has been hypothesized by Gorelikov and Matsuura[84], that CTAB molecules on the AuNR
serve as the organic template for the formation of the mesoporous silica coating via base-
catalyzed hydrolysis of TEOS and subsequent condensation of silica onto the surface of the
CTAB molecules. The eect of the silica coating is to improve the stability of the AuNR due
to its mechanical rigidity, while not inuencing the optical properties due to its transparency
at NIR wavelengths. Indeed, studies have shown that the silica-coated AuNR retained their
morphologies to upto 3 times higher uences than bare AuNR[83].
VII. CONCLUDING REMARKS
As we show, AuNR possess vast potential in enhancing the application of PA imaging
due to their plasmon resonance-driven optical absorptions at the red and NIR wavelengths.
Pre-clinical studies on mice and rats have convincingly demonstrated that the sensitivity
of PA imaging and specicity to the disease are improved by using appropriately targeted
AuNR. The use of these NRs for these applications is set to intensify as great strides are
being made in the technology relating to PA instrumentation, while new NR synthetic
protocols are becoming available and new disease targets are being pursued with the use
of anity molecules such as antibodies and ligands. While much has been learnt from
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the initial use of AuNR, there are many gaps in our understanding of behavior at the
nanoscale especially in synthesis of the particles and their interactions with living media.
A better understanding of the underlying mechanisms of synthesis will provide a handle
toward the desired reproducible control over AuNR sizes and shapes, that will accelerate the
transition of certain synthetic routes from laboratory protocols to manufacturing processes.
For the application of AuNR to move into the crucial phase of clinical trials a complete
understanding of particle interactions with various biological specimens is required. While
detoxication is at the moment performed downstream of synthetic protocols which employ
toxic components, it is imperative that non-toxic green chemicals be used for synthesis.
At this moment, not much research has been conducted in this regard. In addition for in
vivo use, there exist several biological and biophysical challenges presented to AuNR (and
other nanoparticles) in reaching the targeted site following administration into the body.
The particles need to extravasate the vascular compartment, avoid uptake by organs of the
reticuloendothelial system, penetrate through the interstitium, bind to and be taken-up by
the target cells. Much work is still required to overcome the barriers, but these challenges
are similar to those faced in conventional drug delivery where there is more experience with
several creative solutions being researched, which will help the AuNR delivery problem.
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